๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunotherapy for superficial bladder cancer

โœ Scribed by Ellen A. M. Schenk-Braat; Chris H. Bangma

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
251 KB
Volume
54
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Superficial bladder cancer
Superficial bladder cancer
โœ Harris, Jules E. ;Trybula, Marion ;King, Mary ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 711 KB

A 41-year-old white woman first noted painless hematuria at the age of 16. However, evaluation did not include cystoscopy until 7 years prior to admission, at which time a 3.5 cm diameter grade 11, noninfiltrating bladder carcinoma was noted near the right ureteral orifice. There was no known occupa

Superficial bladder cancer
Superficial bladder cancer
โœ L. Boccon-Gibod ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 74 KB
Immunotherapy of bladder cancer
Immunotherapy of bladder cancer
โœ Unyime O. Nseyo; Donald L. Lamm ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB ๐Ÿ‘ 2 views

Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e., Ta, Tl, and carcinoma in situ) with specific objectives which include treating existing/residual tumor, preventing recurrence of tumor, preventing disease progression,